Endo (NASDAQ:ENDP) shares surged 3% in Tuesday’s trading session, after the drug maker posted solid first-quarter performance driven by sterile injectables and core brands. Specifically, total …
A NYT article has Wall Street abuzz today with whispers of non-profit hospital groups creating a new generics maker or partnering with third party manufacturers.
Endo International plc (NASDAQ:ENDP) shares are up nearly 3% in Monday’s trading session, after the drug maker pre-announced Q3 EPS of $0.85, solidly above …
Despite Endo International plc – Ordinary Shares (NASDAQ:ENDP) delivering a second-quarter earnings beat on Tuesday, with the management team forced to pull back …
Valeant Still Has Higher Risk Profile Despite ‘Solid’ Q2 Results Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares crashed 10% yesterday after the troubled biotech …
Twilio Bounces Back with a Strong 2Q Investors are most pleased with Twilio Inc (NYSE:TWLO) second-quarter earnings, sending shares of the communications-software maker …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that it has reached agreements to resolve virtually all known U.S.
Teva Falling Under Sends Oppenheimer to the Sidelines Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is looking at having to slash 7,000 jobs from …
In a research report released Monday, Oppenheimer analyst Derek Archila reiterated a Perform rating on shares of Endo International plc (NASDAQ:ENDP), while estimating fair …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced it has entered into a definitive agreement to sell Mexico City based Grupo Farmacéutico SOMAR to Advent International for approximately $124 million subject …
